Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to CU20080041ApriorityCriticalpatent/CU23604B7/en
Publication of CU20080041A7publicationCriticalpatent/CU20080041A7/en
Publication of CU23604B7publicationCriticalpatent/CU23604B7/en
La presente invención proporciona compuestos de fórmula (I) ESPACIO PARA FÓRMULA o una de sus sales o sosolvatos farmacéuticamente aceptables, métodos para su preparación, métodos para su uso y formulaciones farmacéuticas que los comprenden.The present invention provides compounds of formula (I) SPACE FOR FORMULA or one of its pharmaceutically acceptable salts or sosolvates, methods for its preparation, methods for its use and pharmaceutical formulations comprising them.
Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer.